Divi's Laboratories Ltd.

Financial

	Divi's Lab	Aurobindo Pharma	Laurus Labs
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.91 %	5.41 %	4.8 %
Financials
5 yr Average ROE	19.83 %	15.24 %	20.49 %
5yr average Equity Multiplier	1.24	1.59	2.07
5yr Average Asset Turnover Ratio	0.57	0.72	0.76
5yr Avg Net Profit Margin	27.57 %	13.0 %	12.66 %
Price to Book	8.27	2.4	5.86
P/E	75.83	24.38	150.16
5yr Avg Cash Conversion Cycle	141.33 Days	-29.67 Days	86.64 Days
Inventory Days	115.55 Days	60.22 Days	104.93 Days
Days Receivable	98.41 Days	30.42 Days	88.66 Days
Days Payable	95.88 Days	111.73 Days	140.44 Days
5yr Average Interest Coverage Ratio	995.2	43.11	9.21
5yr Avg ROCE	24.63 %	18.43 %	24.83 %
5yr Avg Operating Profit Margin	39.96 %	20.43 %	24.94 %
5 yr average Debt to Equity	0.0	0.27	0.57
5yr CAGR Net Profit	6.15 %	-4.01 %	52.94 %
5yr Average Return on Assets	15.99 %	9.53 %	9.8 %
Shareholdings
Promoter Holding	51.92 %	51.83 %	27.19 %
Share Pledged by Promoters	0.0	20.86 %	0.0
Change in Promoter Holding (3 Yrs)	-0.03 %	-0.11 %	-0.26 %
Change in Mutual Fund Holding (3 Yrs)	1.69 %	8.99 %	4.63 %

Business

	Divi's Lab	Aurobindo Pharma	Laurus Labs
Product Wise Break-Up	Product Wise Break-Up API 49.0 Custom Synthesis 41.0 Nutraceuticals 10.0 API 0 Formulations 0 Bio 0 Generics FDF 0 Ingredients 0 Synthesis 0 Generic API 0	Product Wise Break-Up Bio 0 Nutraceuticals 0 Synthesis 0 Ingredients 0 Active Pharmaceutical Ingredient (API) 13.98 Custom Synthesis 0 Formulations 86.02 Generic API 0 Generics FDF 0	Product Wise Break-Up Bio 2.0 Nutraceuticals 0 Synthesis 16.0 Ingredients 0 API 0 Custom Synthesis 0 Formulations 0 Active Pharmaceutical Ingredient (API) 52.0 Formulations 30.0
Location Wise Break-Up	Location Wise Break-Up Europe 40.13 USA 28.87 Asia Pacific 13.63 India 11.46 Rest of the World 4.58 North America 0 Others 1.33	Location Wise Break-Up North America 0 India 11.0 Asia Pacific 0 Rest of the World 14.4 Europe 23.5 USA 51.1	Location Wise Break-Up North America 12.0 India 0 Asia Pacific 0 Rest of the World 40.0 Europe 48.0 USA 0
Brand Wise Break-Up	Brand Wise Break-Up Naproxen and Dextromethorphan HBr 26.0 Others 74.0	-	-
Asset Break-Up	Asset Break-Up India 99.92 USA 0.05 Europe 0 Others 0.03	Asset Break-Up India 60.08 Europe 8.77 USA 24.19 Others 6.96	-